← Back to Patent Explorer
US4396608A Expired / Lapsed US ⏱️ 0.0 years remaining

Intravenously injectable immune serum globulin

Assignee: Bayer Corp
•
Filing: 1981-08-24
•
Granted: 1983-08-02
•
Expires: 2001-08-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A composition is disclosed which comprises a solution in a pharmaceutically acceptable carrier of an immune serum globulin, said solution having an ionic strength and a pH to maintain the monomer content and the actual and latent anticomplement activity of the immune serum globulin such that the composition is intravenously injectable. Novel methods are disclosed for preparing the above composition.

Inventors

  • 👤 Robert A. Tenold

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 23:53
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/395; A61K39/39591

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 51 words
A stable, sterile, intravenously injectable pharmaceutical composition comprising an aqueous solution of a therapeutic amount of an immune serum globulin, said solution having an ionic strength such that the solution at 5% protein concentration has a nephelometric reading less than 15 NTU, a pH of about 3.5-5.0, and a physiologically-acceptable tonicity.
Claim 2
Dependent Claim 51 words
A stable, sterile, intravenously injectable pharmaceutical composition comprising an aqueous solution of a therapeutic amount of an immune serum globulin, said solution having an ionic strength such that the solution at 5% protein concentration has a nephelometric reading less than 15 NTU, a pH of about 3.5-5.0, and a physiologically-acceptable tonicity.
Claim 3
Dependent Claim 11 words
The composition of claim 1 which further includes other blood products.
Claim 4
Dependent Claim 32 words
The composition of claim 1 which includes a material selected from the group consisting of carbohydrates, sugar alcohols, and amino acids in an amount sufficient to render physiologically-acceptable tonicity to the solution.
Claim 5
Dependent Claim 10 words
The composition of claim 3 wherein the carbohydrate is maltose.
Claim 6
Dependent Claim 11 words
The composition of claim 3 wherein the amino acid is glycine.
Claim 7
Independent Claim 95 words
A method for treating immune serum globulin which comprises (a) forming an aqueous solution of an immune serum globulin, (b) adjusting the pH of said solution to about 3.5-5.0 by addition of a physiologically acceptable acid, (c) treating the solution to reduce its ionic strength (Γ/2) while maintaining the pH of said solution at 5% protein concentration has a nephelometric reading less than 15 NTU, and (d) adjusting the tonicity of the solution to a physiologically acceptable level by addition of an agent selected from the group consisting of amino acids, carbohydrates, and sugar alcohols.
Claim 8
Independent Claim 95 words
A method for treating immune serum globulin which comprises (a) forming an aqueous solution of an immune serum globulin, (b) adjusting the pH of said solution to about 3.5-5.0 by addition of a physiologically acceptable acid, (c) treating the solution to reduce its ionic strength (Γ/2) while maintaining the pH of said solution at 5% protein concentration has a nephelometric reading less than 15 NTU, and (d) adjusting the tonicity of the solution to a physiologically acceptable level by addition of an agent selected from the group consisting of amino acids, carbohydrates, and sugar alcohols.
Claim 9
Dependent Claim 20 words
The method of claim 6 wherein the solution in Step a has a protein concentration of about 0.5-20% by weight.
Claim 10
Dependent Claim 22 words
The method of claim 6 wherein the pH is adjusted to about 3.8-4.2 in Step b and maintained thereat in Step c.
Claim 11
Dependent Claim 13 words
The method of claim 6 wherein the solution is diafiltered in Step c.
Claim 12
Dependent Claim 15 words
The method of claim 6 which further includes the step of (e) sterilizing the solution.
Claim 13
Dependent Claim 8 words
A composition comprising the product of claim 6.
Claim 14
Dependent Claim 17 words
The method of claim 6 which further includes the step of lyophilizing the solution of Step c.
Claim 15
Dependent Claim 8 words
A composition comprising the product of claim 12.
Claim 16
Dependent Claim 40 words
A dry composition comprising immune serum globulin which upon solution in water has a pH of about 3.5-5.0 and an ionic strength (Γ/2) such that the solution at 5% protein concentration has a nephelometric reading less than about 15 NTU.
Claim 17
Dependent Claim 40 words
A dry composition comprising immune serum globulin which upon solution in water has a pH of about 3.5-5.0 and an ionic strength (Γ/2) such that the solution at 5% protein concentration has a nephelometric reading less than about 15 NTU.

References Cited (Backward Citations)

US4093606A Cited
US4186192A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-08-01 1987-01-31 1987-08-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-08-01 1991-01-31 1991-08-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-08-01 1995-01-31 1995-08-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag